Live Breaking News & Updates on Prnewswire Astellas Pharma Inc

Stay updated with breaking news from Prnewswire astellas pharma inc. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

U.S. FDA ACKNOWLEDGES ASTELLAS' RESUBMISSION OF BIOLOGICS LICENSE APPLICATION FOR ZOLBETUXIMAB AND SETS NEW ACTION DATE

/PRNewswire/ Astellas Pharma Inc. (TSE: 4503, President and CEO: Naoki Okamura, "Astellas") today announced that the U.S. Food and Drug Administration (FDA). ....

United States , United Kingdom , Moitreyee Chatterjee Kishore , Naoki Okamura , Rare Diseases Information Center , Translational Sciences , American Cancer Society , Japan Ministry Of Health , National Institutes Of Health Center , Prnewswire Astellas Pharma Inc , National Cancer Institute , American Society Of Clinical Oncology , End Results Program , Drug Administration , Oncology Development , Astellas Pharma Inc , Biologics License Application , Prescription Drug User Fee Act , Senior Vice President , Immuno Oncology Development , Locally Advanced Unresectable Metastatic Gastric , Gastroesophageal Junction , South America , Clinical Oncology , Cancers Symposium , Nature Medicine ,

Astellas Announces a Collaboration with YASKAWA to Create an Innovative Cell Therapy Ecosystem through the Integration of Pharmaceutical and Robotics Technologies

- Focuses on digitizing cell manufacturing processes through robotics technology
TOKYO, May 21, 2024 /PRNewswire/ Astellas Pharma Inc. today announced that it signed a memorandum of. ....

Naoki Okamura , Astellas Pharma Inc , Prnewswire Astellas Pharma Inc , Safety Of Products Including Pharmaceuticals , Robotic Biology Institute , Medical Device , Astellas Pharma , Cell Therapy Platform Combining Robotics , Medical Device Act , Securing Quality , Products Including Pharmaceuticals , Focus Area Approach ,

Astellas Announces A Collaboration With YASKAWA To Create An Innovative Cell Therapy Ecosystem Through The Integration Of Pharmaceutical And Robotics ...

- Focuses on digitizing cell manufacturing processes through robotics technologyTOKYO, May 21, 2024 /PRNewswire/ Astellas Pharma Inc. ( ....

Naoki Okamura , Robotic Biology Institute , Prnewswire Astellas Pharma Inc , Astellas Pharma Inc , Safety Of Products Including Pharmaceuticals , Medical Device , Astellas Pharma , Cell Therapy Platform Combining Robotics , Medical Device Act , Securing Quality , Products Including Pharmaceuticals , Focus Area Approach ,

Astellas Announces a Collaboration with YASKAWA to Create an Innovative Cell Therapy Ecosystem through the Integration of Pharmaceutical and Robotics Technologies - Astellas Pharma (OTC:ALPMY)

- Focuses on digitizing cell manufacturing processes through robotics technology TOKYO, May 21, 2024 /PRNewswire/ Astellas Pharma Inc. (TSE: 4503, President and CEO: Naoki Okamura, "Astellas") today announced ....

Naoki Okamura , Astellas Pharma Inc , Safety Of Products Including Pharmaceuticals , Robotic Biology Institute , Prnewswire Astellas Pharma Inc , Medical Device , Astellas Pharma , Cell Therapy Platform Combining Robotics , Medical Device Act , Securing Quality , Products Including Pharmaceuticals , Focus Area Approach ,

Astellas' XTANDI™ (Enzalutamide) Granted European Commission Approval for Use in Additional Recurrent Early Prostate Cancer Treatment Setting

/PRNewswire/ Astellas Pharma Inc. (TSE: 4503, President and CEO: Naoki Okamura, "Astellas") today announced the European Commission (EC) has approved a. ....

United States , Comunidad Autonoma De Cataluna , Antonio Alcaraz , Ahsan Arozullah , European Union , Drug Administration , European Association Of Urology , European Commission , Department Of Urology , American Society Of Clinical Oncology , University Hospital Clinic Of Barcelona , Committee For Medicinal Products Human Use , European Medicines Agency , Astellas Pharma Inc , Prnewswire Astellas Pharma Inc , Head Of Oncology Development , European Association , University Hospital Clinic , Europa Uomo , Senior Vice President , Oncology Development , Medicinal Products , Human Use , Receives Positive , Medicines Agency Validates Type , Non Metastatic Hormone Sensitive Prostate Cancer ,